methanogenesis pathway. F1000Res. 2016 Apr;5:606.
14. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical guideline: Small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115(2):165–178.
15. Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American consensus. Am J Gastroenterol. 2017;112(5):775–784.
16. Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: Antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2013;38(8):925–934.
17. Smolka AJ, Schubert ML. Helicobacter pylori – induced changes in gastric acid secretion and upper gastrointestinal disease. Curr Top Microbiol Immunol. 2017;400:227–252.
18. Synthetic Biologics Inc. Synthetic biologics provides update on investigatorsponsored phase 2b clinical study of SYN-010 in IBS-C patients. Available at www.prnewswire.com/news-releases/synthetic-biologics-provides-update-on-investigator-sponsored-phase-2b-clinical-study-of-syn-010-in-ibs-c-patients-301144645.html. Accessed January 2, 2022.
19. Vici G, Camilletti D, Polzonetti V. Possible role of vitamin D in celiac disease onset. Nutrients. 2020 Apr;12(4):1051. doi:10.3390/nu12041051.
20. Vijayvargiya P, Camilleri M. Update on bile acid malabsorption: Ready for prime time? Curr Gastroenterol Rep. 2018;20(3):10.
21. Vijayvargiya P, Gonzalez Izundegui D, Calderon G, Tawfic S, Batbold S, Camilleri M. Fecal bile acid testing in assessing patients with chronic unexplained diarrhea: Implications for healthcare utilization. Am J Gastroenterol. 2020;115(7):1094–1102.
Глава 7
1. Chandan S, Mohan BP, Chandan OC, et al. Curcumin use in ulcerative colitis: Is it ready for prime time? A systematic review and meta-analysis of clinical trials. Ann Gastroenterol. 2020;33(1):53–58.
2. Dang X, Xu M, Liu D, Zhou D, Yang W. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL3 for active ulcerative colitis: A systematic review and meta-analysis. PLoS One. 2020;15(3):e0228846.
3. Griffin N, Grant LA, Anderson S, Irving P, Sanderson J. Small bowel MR enterography: Problem solving in Crohn’s disease. Insights Imaging. 2012;3(3):251–263.
4. Heerasing N, Thompson B, Hendy P, et al. Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn’s disease. Aliment Pharmacol Ther. 2017;45(5):660–669.
5. Levine A, Rhodes JM, Lindsay JO, et al. Dietary guidance from the International Organization for the Study of Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020;18(6):1381–1392.
6. Lewis JD, Sandler RS, Brotherton C, et al. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn’s disease. Gastroenterology. 2021;161(3):837–852.e9.
7. Manitius N. Fiber for Inflammatory Bowel Disease (patient education handout). Dietitians in Medical Nutrition Therapy, a dietetic practice group of the Academy of Nutrition and Dietetics. 2021.
8. Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: Prospective cohort study. BMJ. 2021;374:n1554.
9. Nguyen DL, Palmer LB, Nguyen ET, McClave SA, Martindale RG, Bechtold ML. Specialized enteral nutrition therapy in Crohn’s disease patients on maintenance infliximab therapy: A meta-analysis. Therap Adv Gastroenterol. 2015;8(4):168–175.
10. Su GL, Ko CW, Bercik P, et al. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 2020;159(2):697–705.
Глава 8
1. Chin KW, Garriga MM, Metcalfe DD. The histamine content of oriental foods. Food Chem Toxicol. 1989;27(5):283–287.
2. Chung BY, Cho SI, Ahn IS, et al. Treatment of atopic dermatitis with a low-histamine diet. Ann Dermatol. 2011;23 Suppl 1:S91–S95.
3. Comas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, Latorre-Moratalla M, Vidal-Carou MDC. Histamine intolerance: The current state of the art. Biomolecules. 2020;10(8):1181.
4. Feldman JM. Histaminuria from histamine-rich foods. Arch Intern Med. 1983;143(11):2099–2102.
5. Ganesh A, Maxwell LG. Pathophysiology and management of opioid-induced pruritus. Drugs. 2007;67(16):2323–2333.
6. Hermens JM, Hanifin JM, Hirschman CA. Comparison of histamine release in human skin mast cells induced by morphine and fentanyl as supplements to nitrous oxide anesthesia. Anesthesiology. 1985;62:124–129.
7. Hrubisko M, Danis R, Huorka M, Wawruch M. Histamine intolerance – the more we know the less we know. A review. Nutrients. 2021;13(7):2228.
8. Joneja JV. Dealing with Food Allergies: A Practical Guide to Detecting Culprit Foods and Eating a Healthy, Enjoyable Diet. Bull Publishing Company; 2003.
9. Joneja JV. Histamine Intolerance: A Comprehensive Guide for Healthcare Professionals. 1st ed. Lawrence H, ed. Berrydale Books; 2017.
10. Komericki P, et al. Histamine intolerance: Lack of reproducibility of single symptoms by oral provocation with histamine: A randomised, double-blind, placebo-controlled cross-over study. Wiener Klinische Wochenschrift. 2011; 123(1–2):15–20.
11. Leitner R, Zoernpfenning E, Missbichler A. Evaluation of the inhibitory effect of various drugs/active ingredients on the activity of human diamine oxidase in vitro. Clin Transl Allergy. 2014;4(Suppl 3):P23.
12. Maintz L, et al. Evidence for a reduced histamine degradation capacity in a subgroup of patients with atopic eczema. J Allergy Clin Immunol. 2006;117.5:1106–1112.
13. Manzotti G, Breda D, Di Gioacchino M, Burastero SE. Serum diamine oxidase activity in patients with histamine intolerance. Int J Immunopath Pharmacol. 2016;29:105–111.
14. McNicol E, Horowicz-Mehler N, Fisk RA. Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. Journal of Pain. 2003;4(5):231–256.
15. Reese I, Ballmer-Weber B, Beyer K, et al. German guideline for the management of adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Association of Allergologists (AeDA), and the Swiss Society for Allergology and Immunology (SGAI). Allergo J Int. 2017;26(2):72–79.
16. Sánchez-Pérez S, Comas-Basté O, Rabell-González J, Veciana-Nogués MT, Latorre-Moratalla ML, Vidal-Carou MC. Biogenic amines in plant-origin foods: Are they frequently underestimated in low-histamine diets? Foods. 2018;7(12):205.
17. Schink M, Konturek PC, Tietz E, et al. Microbial patterns in patients with histamine intolerance. J Physiol Pharmacol. 2018;69(4):10.26402/jpp.2018.4.09.
18. Schnedl WJ, Enko D. Histamine intolerance originates in the gut. Nutrients. 2021;13(4):1262.
19. Schnedl WJ, Schenk M, Lackner S, Enko D, Mangge H, Forster F. Diamine oxidase supplementation improves symptoms in patients with histamine intolerance. Food Sci. Biotechnol. 2019;28:1779–1784.
20. Schwelberger, HG. Histamine intolerance: A metabolic disease? Inflamm Res. 2010; 59.2:219–221.
21. Slorach SA. Chapter 15, Histamine in Food. In: Uvnäs B, ed. Histamine and Histamine Agonists. Springer-Verlag Berlin Heidelberg; 1991.
22. Son JH, Chung BY, Kim HO, Park CW. A histamine-free diet is helpful for treatment of adult patients with chronic spontaneous urticaria. Ann Dermatol. 2018;30(2):164–172.
23. Tuck CJ, Biesiekierski JR, Schmid-Grendelmeier P, Pohl D. Food intolerances. Nutrients. 2019;11(7):1684.
24. University of Maryland Medical Center Website. Quercetin. http://accurateclinic.com/wp-content/uploads/2016/02/Quercetin-University-of-Maryland-Medical-Center.pdf. Accessed December 12, 2021.
25. Wantke F, Götz M, Jarisch R. The red wine provocation test: Intolerance to histamine as a model for
